When looking for the best stocks to buy and watch, focus on those with rising relative price strength.
One stock that fits that bill is Novartis ADR, which saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 88 to 92.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. IBD's unique RS Rating identifies market leadership by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
Over 100 years of market history shows that the best stocks tend to have an RS Rating of above 80 as they begin their largest climbs.
Looking For The Best Stocks To Buy And Watch? Start Here
Novartis ADR is now considered extended and out of buy range after clearing a 93.41 buy point in a first-stage flat base. See if the stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.
Earnings Report
Novartis ADR saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 9% to 11,612%. Revenue rose from -4% to 3%.
Novartis ADR holds the No. 5 rank among its peers in the Medical-Ethical Drugs industry group. Novo Nordisk ADR and Sanofi ADR are among the top 5 highly rated stocks within the group.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
